Ab Initio's Chief Scientific Officer recognised for significant accomplishments within the field

Dr Hui Xin Ong (YY) | Chief Scientific Officer |Ab Initio Pharma Pty Ltd

Ab Initio’s Chief Scientific Officer, Dr Hui Xin Ong (YY) has been awarded the 2021 Drug Delivery to the Lungs (DDL) Emerging Scientist Award. This prestigious award recognises significant scientific accomplishment and innovation of an early career researcher working in the area of inhalation science.

Dr Ong stated ‘I am truely honoured to receive such a prestigious award, it is very humbling to be recognised for my contributions to the field at such an early stage of my career. My passion is to see innovations in respiratory medicine translate from the lab into trials products to help people suffering from respiratory diseases. I hope the pre-clinical tools that I have developed will aid start-ups and innovators make that transition easier.

YY is a co-founder and Chief Scientific Officer of Ab Initio Pharma, a pharmaceutical formulation R&D and GMP Manufacturing company based in Sydney, Australia. Established as a spin-off supported by MTP Connect, from the University of Sydney in partnership with Sydney Local Health District and the peak industry body, ARCS. The company provides innovators across Australia and globally with a flexible platform to rapidly translate bench-top discoveries to clinical trial products and fully-fledged commercial pharmaceuticals.

YY is also a Research Fellow at the Department of Biomedical Sciences, Faculty of Medicine, Macquarie University and a Research Leader at the Woolcock Institute of Medical Research, which is ranked by the influential Times Higher Education as the top specialist sleep and respiratory health research centre in the world.

DDL is a premier conference and industry exhibition, dedicated to pulmonary and nasal drug delivery and is linked to the Aerosol Society of Great Britain. In 2017 DDL Committee introduced an award to recognise specific individuals who are early on in their career in inhalation science and who have achieved significant scientific accomplishment within the field. As an awardee, Dr Ong gave the annual DDL Emerging Scientist Award Podium and received a prestigious award in recognition of her contributions.

Previous
Previous

Merry Christmas

Next
Next

Learn how Ab Initio is helping start-ups translate therapeutics to the clinic